RHOH and neoplasm: However, it was found that the binding between the fusion protein of (RGD)2-tTF (double RGD peptide) and αvβ3 receptor for targeting the tumor vasculature was not significantly stronger than the binding of RGD-tTF and αvβ3 receptors [31].